Discovery of Novel Blood Biomarkers for PTSD and TBI

Biological Psychiatry 2018; 83(9): S134-135. Supplement
Authored By:
Fossati S, Cejudo JR, Genfi A, Abu-Amara D, Marmar C
The development of blood biomarkers for PTSD and TBI is an extremely critical area of research. Easily detectable blood biomarkers are needed for diagnostic purposes, to establish therapeutic efficacy, to better understand the biology underlying these disorders.
Published in:
Biological Psychiatry

More Publications

April 18, 2024

Nature Genetics

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

March 5, 2024

Translational Psychiatry

Potential causal association between gut microbiome and posttraumatic stress disorder

January 29, 2024

Scientific Reports

Differential recruitment of brain circuits during fear extinction in non-stressed compared to stress resilient animals

December 29, 2023

Journal of Law and the Biosciences

Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and security context

August 1, 2023

Journal of Psychopharmacology

Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)

July 29, 2023

Frontiers in Neurology

Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders